Suministro de medicamento exclusivo Ravulizumab
TED · 636520-2026Award notice · social & specific servicesNo deadline given
Value
Estimated€333,746 · 333,745.7 EUR
Awarded€157,771 · 157,770.69 EUR
Who already wins at this buyer
Firms with recorded awards from Hospital Infantil Universitario Niño Jesús in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ALEXION PHARMA SPAIN, S.L | 2 | €4,418,162 | 2026-07-21 |
| VERTEX PHARMACEUTICALS SPAIN, S.L | 2 | €1,115,324 | 2026-06-04 |
| EUROMED PHARMA SPAIN S.L. | 2 | €849,638 | 2026-08-31 |
| ICU MEDICALPRODUCTOS FARMACEÚTICOS Y HOSPITALARIOS, S.L. | 2 | €279,837 | 2026-08-28 |
| BIOMARIN PHARMACEUTICALS ESPAÑA S.L. | 1 | €77,601,945 | 2026-09-02 |
Full buyer profile: what Hospital Infantil Universitario Niño Jesús buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de medicamento exclusivo Ravulizumab 300mg/3ml concentrado para solución para perfusión 1 vial de 3 ml
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-12 | Suministro de medicamento exclusivo Ravulizumab | Hospital Infantil Universitario Niño Jesús ES | 100% |
| 2026-07-10 | Suministro de material fungible asociado a bombas de infusión volumétricas modelo PLUM 360 | Hospital Infantil Universitario Niño Jesús ES | 92% |
| 2026-09-02 | Suministro de Medicamentos de distribución exclusiva del laboratorio BIOMARIN PHARMACEUT ESPAÑA S.L. | Hospital Infantil Universitario Niño Jesús ES | 92% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-12 | 2025/1303 - NATALIZUMAB [20 MG/ML 15 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |